Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,553.78
(
-0.41%
)
US TECH 100
23,350.40
(
-0.72%
)
Dow Jones
46,092.58
(
-0.25%
)
Brent Oil
100.16
(
3.48%
)
Bitcoin
70,060.00
(
-1.18%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

oldacct

Send PM Follow Ignore
Followers 0
Posts 114
Boards Moderated 0
Alias Born 10/10/2006

oldacct

Re: jessellivermore post# 6917

Friday, 01/11/2008 10:58:45 AM

Friday, January 11, 2008 10:58:45 AM

Post# of 19309
What you are saying was told to me more than 15 years ago by
Genzyme's former CFO.

Sandra Lehrman tried dealing with BP (Elan, Bristol Myers,Centecor) wasting precious time and money. The closest to using transgenics was Centecor until they merged with J&J.

Genzyme spun off GTC for further financing and to get their losses off Genz income statement.

I believe Genz will be the next partner with a small upfront payment 6-10M and larger milestone payments for the DIC indication.

Let's hope for the best.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today